Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)

SHA:600436 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,347	1,488	1,159	2,496	7,097	5,168
Short-Term Investments	-	3,520	9,014	6,202	-	-
Trading Asset Securities	-	-	-	-	8.8	0.01
Cash & Short-Term Investments	1,347	5,008	10,173	8,698	7,106	5,168
Cash Growth	-58.80%	-50.78%	16.95%	22.42%	37.48%	21.23%
Accounts Receivable	1,051	894.43	1,021	859.49	673.3	574.34
Other Receivables	67.49	67.88	65.15	107.94	134.95	70.11
Receivables	1,119	962.31	1,086	967.43	808.25	644.45
Inventory	6,160	4,967	3,379	2,628	2,438	2,191
Prepaid Expenses	-	12.82	14.05	4.55	20.68	-
Other Current Assets	2,073	378.99	447.9	406.61	261.36	292.18
Total Current Assets	10,699	11,329	15,100	12,705	10,633	8,296
Property, Plant & Equipment	1,767	1,508	614.62	465.62	400.14	274.96
Long-Term Investments	1,347	870.45	631.98	673.7	799.87	979.2
Other Intangible Assets	267.95	273.1	291.09	319.37	220.96	259.38
Long-Term Deferred Tax Assets	141	155.5	187.31	167.26	166.98	85.41
Long-Term Deferred Charges	30.1	34.05	29.99	37.65	44.19	49.42
Other Long-Term Assets	3,226	3,370	225.4	235.41	255.59	261.16
Total Assets	17,479	17,540	17,080	14,604	12,521	10,206
Accounts Payable	541.85	480.01	667.92	464.9	386.99	239.94
Accrued Expenses	153.99	485.41	685.98	345.39	342.14	139.24
Short-Term Debt	831.94	892.79	989.93	970.96	775.79	718.38
Current Portion of Long-Term Debt	40.44	6.99	1.87	-	-	-
Current Portion of Leases	-	35.81	31.86	29.21	22.75	-
Current Income Taxes Payable	136.6	59.07	142.65	72.93	108.96	77.56
Current Unearned Revenue	182.88	270.81	237.1	468.57	326.56	283.75
Other Current Liabilities	253.45	142.92	125.8	158.22	173.9	341.46
Total Current Liabilities	2,141	2,374	2,883	2,510	2,137	1,800
Long-Term Debt	56.08	58.15	35.44	-	-	-
Long-Term Leases	130.48	154.58	107.29	108.8	86.67	-
Long-Term Unearned Revenue	26.01	26.68	17.67	17.01	20.24	14.68
Pension & Post-Retirement Benefits	52.84	53.28	35.04	34.29	32.23	29.42
Long-Term Deferred Tax Liabilities	0.22	0.33	30.02	61.09	74.52	47.47
Other Long-Term Liabilities	31.31	34.1	51.35	48.54	32.88	57.09
Total Liabilities	2,438	2,701	3,160	2,780	2,384	1,949
Common Stock	603.32	603.32	603.32	603.32	603.32	603.32
Additional Paid-In Capital	1,095	1,095	1,095	1,094	1,086	1,085
Retained Earnings	12,683	12,497	11,602	9,559	7,816	5,862
Comprehensive Income & Other	90.68	76.92	76.6	74.41	200.05	311.57
Total Common Equity	14,472	14,272	13,376	11,330	9,705	7,862
Minority Interest	568.41	567.01	544.17	493.97	432.07	394.39
Shareholders' Equity	15,041	14,839	13,920	11,824	10,138	8,257
Total Liabilities & Equity	17,479	17,540	17,080	14,604	12,521	10,206
Total Debt	1,059	1,148	1,166	1,109	885.21	718.38
Net Cash (Debt)	288.09	3,859	9,007	7,589	6,220	4,450
Net Cash Growth	-86.26%	-57.15%	18.67%	22.01%	39.78%	24.77%
Net Cash Per Share	0.48	6.39	14.94	12.59	10.31	7.37
Filing Date Shares Outstanding	603.32	603.32	603.32	603.32	603.32	603.32
Total Common Shares Outstanding	603.32	603.32	603.32	603.32	603.32	603.32
Working Capital	8,558	8,955	12,217	10,195	8,496	6,496
Book Value Per Share	23.99	23.66	22.17	18.78	16.09	13.03
Tangible Book Value	14,204	13,999	13,085	11,011	9,484	7,603
Tangible Book Value Per Share	23.54	23.20	21.69	18.25	15.72	12.60
Buildings	-	1,095	400.13	331.45	332.55	331.29
Machinery	-	368.02	345.33	324.4	300.25	263.39
Construction In Progress	-	314.85	157.19	60.78	14.94	1.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.